As of 3:59pm ET
| +0.01 / +0.58%|
The 6 analysts offering 12-month price forecasts for Galena Biopharma Inc have a median target of 4.25, with a high estimate of 8.00 and a low estimate of 2.00. The median estimate represents a +144.25% increase from the last price of 1.74.
The current consensus among 8 polled investment analysts is to Buy stock in Galena Biopharma Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.